BioNTech / Biopharmaceutical New Technologies
Industry / private company
Location:
Mainz,
Germany (DE)
ROR: https://ror.org/04fbd2g40
Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies (2017)
Breyer J, Wirtz RM, Otto W, Laible M, Schlombs K, Erben P, Kriegmair MC, et al.
Journal article
Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens (2016)
Laible M, Schlombs K, Kaiser K, Veltrup E, Herlein S, Lakis S, Stoehr R, et al.
Journal article
ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC) (2016)
Breyer J, Wirtz RM, Laible M, Schlombs K, Erben P, Kriegmair MC, Stoehr R, et al.
Journal article